glp-1/gip/glucagon triple agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide
Description
Patents and Regulatory Exclusivities on GLP-1 Receptor Agonists
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
However, because glucagon-like peptide-1 receptor agonists work to slow gastric emptying, a safety concern has been raised in patients undergoing deep sedation or general anesthesia regarding gastric aspiration, and considering their long half-life in the blood, they are difficult to manage in the perioperative period
But medications alone cant address every challenge PMOS brings
